CN104357558A - Primer pair for simultaneously detecting API2-MALT1 and NPM-ALK fusion genes by pyrosequencing process and kit - Google Patents

Primer pair for simultaneously detecting API2-MALT1 and NPM-ALK fusion genes by pyrosequencing process and kit Download PDF

Info

Publication number
CN104357558A
CN104357558A CN201410580123.7A CN201410580123A CN104357558A CN 104357558 A CN104357558 A CN 104357558A CN 201410580123 A CN201410580123 A CN 201410580123A CN 104357558 A CN104357558 A CN 104357558A
Authority
CN
China
Prior art keywords
primer
api2
malt1
npm
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410580123.7A
Other languages
Chinese (zh)
Other versions
CN104357558B (en
Inventor
邵棠
陈庆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410580123.7A priority Critical patent/CN104357558B/en
Publication of CN104357558A publication Critical patent/CN104357558A/en
Application granted granted Critical
Publication of CN104357558B publication Critical patent/CN104357558B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a primer pair for simultaneously detecting API2-MALT1 and NPM-ALK fusion genes by a pyrosequencing process and a kit comprising the primer pair. The kit can be used for detecting API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150) and NPM-ALK fusion genes in one time. Primers are designed for mRNAs (messenger ribonucleic acids) of the API2-MALT1 and NPM-ALK fusion genes and a product is subjected to sequencing analysis after reverse transcription PCR (polymerase chain reaction). The kit can be used for quick, accurate and high-flux detection of the API2-MALT1 and NPM-ALK fusion genes.

Description

Manganic pyrophosphate complex initiation method detects primer pair and the test kit of API2-MALT1 and NPM-ALK fusion gene simultaneously
Technical field
The invention belongs to biology field, be specifically related to the primer pair that a kind of Manganic pyrophosphate complex initiation method detects API2-MALT1 and NPM-ALK fusion gene simultaneously, comprise the test kit of described primer pair and the application of this examination box agent.
Background technology
API2-MALT1 fusion gene comprises the broad varietys such as API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150), is common in mucosa-associated lymphoid tissue (MALT) lymphoma; NPM-ALK fusion gene is common in primary cutaneous type (ALCL).
In the method for the outer widely used molecular Biological Detection API2-MALT1 of Present Domestic and NPM-ALK fusion gene, fluorescence in situ hybridization technique (FISH) can only carry out qualitative detection, complicated operation; Quantitative fluorescent PCR also exists the limitation detecting flux, so all really can't meet the needs of clinical diagnosis detection.Traditional solid phase biological chip (Biochip) or biochip technology also exist repeatable poor, insufficient sensitivity good and the outstanding weakness of complex operation.
Pyrosequencing techniques (Pyrosequencing) is DNA sequence analysis technology of new generation, possess the ability of simultaneously a large amount of sample being carried out to sequencing analysis, for high-throughput, low cost, carry out nucleotide analysis and Clinical Laboratory provides ideal technological operation platform quickly and intuitively.
Summary of the invention
Goal of the invention: for the technical problem existed in prior art, the present invention propose introducing that a kind of Manganic pyrophosphate complex initiation method detects API2-MALT1 and NPM-ALK fusion gene simultaneously to and test kit containing described primer pair, API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150) and NPM-ALK many kinds of fusion genes can be detected simultaneously, there is the advantages such as highly sensitive, high specific, split hair caccuracy, detection be rapid.
Technical scheme: for realizing above-mentioned technical purpose, the present invention proposes the primer pair that a kind of Manganic pyrophosphate complex initiation method detects API2-MALT1 and NPM-ALK fusion gene simultaneously, described API2-MALT1 is any one or a few in API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150), it is characterized in that, described primer pair comprises:
(1) for API2-MALT1 (A1446-M814) gene:
Amplimer is:
Upstream primer: 5 '-GAAGCCTGGTAAAACAGACAGTTC-3 ',
Downstream primer: 5 '-CATCAGCTTTTGGGAAGTTGGT-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-CAACACTTCTCTGGAAGC-3′；
(2) for API2-MALT1 (A1446-M1123) gene:
Amplimer is:
Upstream primer: 5 '-GAAGCCTGGTAAAACAGACAGTTC-3 ',
Downstream primer: 5 '-TTTCCTATCAAAAGGGCAACC-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-TGAGGAAAAAGAATCA-3′；
(3) for API2-MALT1 (A1446-M1150) gene:
Amplimer is:
Upstream primer: 5 '-CAGAAGATGAAATAAGGGAAGAGG-3 ',
Downstream primer: 5 '-TATTTCCTATCAAAAGGGCAACC-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-GTCAGTTGTTTGCTCTTTA-3′；
(4) for NPM-ALK gene:
Amplimer is:
Upstream primer: 5 '-CAAAGTGAGATTACAGGCATGAGC-3 ',
Downstream primer: 5 '-GCTGGGATCTTGGTCAGTTGTGT-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer:
5′-GGTCAGTTGTGTTTCCTAT-3′。
Present invention further proposes the test kit that a kind of Manganic pyrophosphate complex initiation method detects API2-MALT1 and NPM-ALK fusion gene simultaneously, described API2-MALT1 is any one or a few in API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123) and API2-MALT1 (A1446-M1150), it is characterized in that, described test kit comprises quality control product and following primer:
(1) for API2-MALT1 (A1446-M814) gene:
Amplimer is:
Upstream primer: 5 '-GAAGCCTGGTAAAACAGACAGTTC-3 ',
Downstream primer: 5 '-CATCAGCTTTTGGGAAGTTGGT-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-CAACACTTCTCTGGAAGC-3′；
(2) for API2-MALT1 (A1446-M1123) gene:
Amplimer is:
Upstream primer: 5 '-GAAGCCTGGTAAAACAGACAGTTC-3 ',
Downstream primer: 5 '-TTTCCTATCAAAAGGGCAACC-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-TGAGGAAAAAGAATCA-3′；
(3) for API2-MALT1 (A1446-M1150) gene:
Amplimer is:
Upstream primer: 5 '-CAGAAGATGAAATAAGGGAAGAGG-3 ',
Downstream primer: 5 '-TATTTCCTATCAAAAGGGCAACC-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-GTCAGTTGTTTGCTCTTTA-3′；
(4) for NPM-ALK gene:
Amplimer is:
Upstream primer: 5 '-CAAAGTGAGATTACAGGCATGAGC-3 ',
Downstream primer: 5 '-GCTGGGATCTTGGTCAGTTGTGT-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer:
5′-GGTCAGTTGTGTTTCCTAT-3′。
Wherein, described quality control product comprises positive reference substance and negative controls, wherein, described positive reference substance is positive control, for the mixed solution of the plasmid containing API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150) and NPM-ALK, described negative controls is negative control, for not containing the plasmid solution of API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150) and NPM-ALK.
The test kit that the invention allows for above-mentioned primer pair and comprise above-mentioned primer pair detects the application in the reagent of API2-MALT1 and NPM-ALK fusion gene in preparation.
Beneficial effect: compared with prior art, the test kit that Manganic pyrophosphate complex initiation method of the present invention detects API2-MALT1 and NPM-ALK fusion gene can realize fast, easy, efficiently, detect API2-MALT1 (A1446-M814) accurately, API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150) and NPM-ALK fusion gene, for for the preparation of detection API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), the reagent of API2-MALT1 (A1446-M1150) and NPM-ALK fusion gene provides theoretical basis.
Embodiment
Experiment material:
Primer is synthesized by invitrogen company; Trizol is purchased from invitrogen company; Reverse transcription cDNA synthetic agent box is purchased in Fermentas company; Multiple PCR reagent kit is purchased in QIAGEN company; Manganic pyrophosphate complex initiation reagent is purchased in QIAGEN company.
A kind of Manganic pyrophosphate complex initiation method detects the test kit of API2-MALT1 and NPM-ALK fusion gene, described API2-MALT1 is any one or a few in API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123) and API2-MALT1 (A1446-M1150), comprises quality control product and following primer:
(1) for API2-MALT1 (A1446-M814) gene:
Amplimer is:
Upstream primer: 5 '-GAAGCCTGGTAAAACAGACAGTTC-3 ',
Downstream primer: 5 '-CATCAGCTTTTGGGAAGTTGGT-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-CAACACTTCTCTGGAAGC-3′；
(2) for API2-MALT1 (A1446-M1123) gene:
Amplimer is:
Upstream primer: 5 '-GAAGCCTGGTAAAACAGACAGTTC-3 ',
Downstream primer: 5 '-TTTCCTATCAAAAGGGCAACC-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-TGAGGAAAAAGAATCA-3′；
(3) for API2-MALT1 (A1446-M1150) gene:
Amplimer is:
Upstream primer: 5 '-CAGAAGATGAAATAAGGGAAGAGG-3 ',
Downstream primer: 5 '-TATTTCCTATCAAAAGGGCAACC-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-GTCAGTTGTTTGCTCTTTA-3′；
(4) for NPM-ALK gene:
Amplimer is:
Upstream primer: 5 '-CAAAGTGAGATTACAGGCATGAGC-3 ',
Downstream primer: 5 '-GCTGGGATCTTGGTCAGTTGTGT-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer:
5′-GGTCAGTTGTGTTTCCTAT-3′。
Wherein, quality control product (quality control product DNA) comprises positive reference substance and negative controls, described positive reference substance, as positive control, is the mixed solution of the plasmid containing API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150) and NPM-ALK; Described negative controls is as negative control, compared with positive reference substance, negative controls is not containing the plasmid solution of API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150) and NPM-ALK.
Detection method comprises the steps:
(1) RNA extracts:
Get the clinical sample of 15 MALT lymphomas or primary cutaneous type patient; The clinical sample of 1 ~ No. 15 patient extracts RNA respectively according to the following steps:
(1) lymphocyte extract: get fresh whole blood 2ml and add 1ml3wt% Trisodium Citrate, after mixing at 4 DEG C the centrifugal 10min of 3000r/min, get pale yellow chromatograph on blood cell layer and be lymphocyte, obtain lymphocyte liquid;
(2) centrifuge tube getting 1 RNase-free adds the lymphocyte liquid 150 μ l in (1), then adds 1ml Trizol, and room temperature places 5min, makes its abundant cracking;
The centrifugal 5min of (3) 12,000r/min, gets supernatant;
(4) in supernatant, add 200 μ l chloroforms, after acute vibration mixing, room temperature places 15min;
Centrifugal 15min under (5) 4 DEG C 12,000g;
(6) draw upper strata aqueous phase, aqueous phase is transferred in another centrifuge tube;
(7) in aqueous phase, add 500 μ l Virahol mixings, room temperature places 5 ~ 10min;
Centrifugal 10min under (8) 4 DEG C 12,000g, abandons supernatant, and RNA is sunken at the bottom of pipe;
(9) in the pipe of step (8), add 1ml75% (v/v) ethanol, gentle vibration centrifuge tube, suspend precipitation;
(10) 4 DEG C of 8,000g centrifugal 5min, abandons supernatant as far as possible;
(11) room temperature is dried or vacuum-drying 5 ~ 10min;
(12) with 50ul RNase-free dH 2o dissolves RNA sample, 55 ~ 60 DEG C, 5 ~ 10min;
(13) the quantitative RNA concentration of OD value is surveyed.
According to above-mentioned steps, obtain the mRNA of 1 ~ No. 15 sample respectively.
(2) multiple reverse transcription pcr amplification:
As follows multiple reverse transcription pcr amplification is carried out to the mRNA of above-mentioned 1 ~ No. 15 sample:
(1) synthesis of cDNA first chain
1. get the centrifuge tube of a RNase-free, be placed on ice, set up following reaction system;
Total RNA 5～10μg/3μl
Oligo(dT)18 Primer(0.5μg/μl) 1μl
RNase-free dH 2o adds to 12 μ l
Mix reaction solution gently, with the reaction solution on the centrifugal a little collection tube wall of refrigerated centrifuge at the bottom of pipe;
2. centrifuge tube was in 70 DEG C of incubations 5 minutes, took out rapidly to be afterwards placed in ice and to cool, with the reaction solution on the centrifugal a little collection tube wall of refrigerated centrifuge at the bottom of pipe;
3. centrifuge tube is positioned on ice, is sequentially added into following reaction solution;
5×reaction buffer 4μl
RNase Inhibitor(20U/μl) 1μl
10mM dNTPs Mix 2μl
Mix reaction solution gently, with the reaction solution on the centrifugal a little collection tube wall of refrigerated centrifuge at the bottom of pipe;
4. centrifuge tube was in 37 DEG C of incubations 5 minutes;
5. add 1 μ l RevertAidTM Reverse Transcriptase (200U/ μ l), final volume is 20 μ l;
6. centrifuge tube was in 42 DEG C of reactions 60 minutes;
7. centrifuge tube is in 70 DEG C of heating, 10 minutes termination reactions, and rapid taking-up is afterwards placed in ice and cools.
So, synthesis cDNA first chain, i.e. template cDNA (Template cDNA).
(2) multiplex PCR
What adopt is the Multiplex PCR kit of QIAGEN company, and system is as follows
Wherein, warm start TaqDNA enzyme, MgCl is contained in 2 × QIAGEN Multiplex PCR Master Mix 2with dNTP Mix; 10 × Primer mix is the mixture comprising above-mentioned several fusion gene primer pair.
Pcr amplification program: 95 DEG C of 15min; 94 DEG C of 30s, 55 DEG C of 90s, 72 DEG C of 90s, 35 circulations; 72 DEG C of 10min; 4 DEG C of insulations.
By above-mentioned steps, obtain PCR primer.
(3) Manganic pyrophosphate complex initiation
First, fix PCR primer with microballon, biotin labeled PCR primer is mainly fixed on the Agarose microbead (Streptavidin Sepharose High Performance) of Streptavidin bag quilt by it, comprises the steps:
(1) jog bag is by the Agarose microbead of Streptavidin, until obtain homogeneous solution;
(2) in a test tube, mix the Agarose microbead total amount (2 μ l/ sample) of Streptavidin bag quilt and binding buffer liquid (40 μ l/ sample), add ultrapure water to certain volume, this volume and the follow-up summation will adding the volume of the biotin labeled PCR primer optimized are 80 μ l/ holes;
(3) solution of the certain volume obtained in (2) is added in 24 hole PCR orifice plates;
(4) arrange according to orifice plate, the biotin labeled PCR primer that interpolation 5 ~ 20 μ l have optimized, to each hole slot of PCR orifice plate, makes wherein solution contained by every hole be 80 μ l;
(5) use orifice plate bar lid sealing PCR orifice plate, guarantee not leak between hole slot;
(6) shaker mixer (1400rpm) continuous vibration PCR orifice plate at least 5 ~ 10 minutes are used.
Through above-mentioned steps, biotin labeled PCR primer is fixed on the Agarose microbead of Streptavidin bag quilt.
Then, start vacuum work station preparation work, comprise the steps:
(1) following reagent is prepared: approximately 50ml 70% (v/v) ethanol; About 40ml denaturing soln (QIAGEN company); About 50ml 1 × lavation buffer solution (QIAGEN company)); About 50ml ultrapure water; About 70ml ultrapure water;
(2) open vacuum pump: open vacuum switch, carry out testing experiment, to determine whether filter probe normally works;
(3) permeability of filter probe is detected before each use vacuum pump with ultrapure water, centrifuge tube previously prepd being installed ultrapure water is inserted in PCR device, filter probe is fallen in ultrapure water, ultrapure water, as being evacuated in 20 seconds, shows that filter probe is normal, can use, otherwise then need to change filter probe;
(4) take off the PCR orifice plate vibrated, sample is put into PCR device, carefully fall filter probe in PCR orifice plate, stop 15 seconds; Guarantee that solution is all sucked away, to catch the microballon containing fixed die plate;
(5) vacuum unit is moved to the first reagent trough containing 70% (v/v) ethanol, washing and filtering probe 5 seconds;
(6) vacuum unit is moved to the second reagent trough containing denaturing soln, washing and filtering probe 5 seconds;
(7) vacuum unit is moved to the 3rd reagent trough containing lavation buffer solution, washing and filtering probe 10 seconds;
(8) vacuum unit is raised more than 90 ° of vertical lines 5 seconds, discharge opeing from filter probe;
(9) grip vacuum unit on Q24 orifice plate, the vacuum switch on stopping device unsettled stop 5 seconds, allow negative pressure leave;
(10) by left and right jog vacuum unit, release pearl is in the orifice plate containing 3 kinds of sequencing primers;
(11) when vacuum unit cuts out, vacuum unit is transferred to the 4th reagent trough containing ultrapure water, vibrates 10 seconds;
(12) fall probe to another containing ultrapure water the 5th reagent trough in and apply vacuum, cleaning probe, with 70ml ultrapure water filter probe;
(13) vacuum unit is raised more than 90 ° of vertical lines 5 seconds, discharge opeing from filter probe;
(14) close the switch on vacuum unit, and be placed on static (P) position.
Change like this completes the preparation work of vacuum station, then starts DNA isolation strand and is discharged into by sample in PyroMark Q24 orifice plate, comprising the steps: particularly
(1) 80 DEG C of exact heat 2 minutes on orifice plate base PyroMark Q24 orifice plate being placed on preheating;
(2) take off orifice plate from orifice plate base, make sample at room temperature at least cool 5 minutes.
Through above-mentioned steps, sample is discharged in PyroMark Q24 orifice plate by cup.Then prepare PyroMark Q24 reagent, carry out in the steps below:
(1) open PyroMark Q24 test kit and take out the bottle containing enzyme and substrate lyophilized powder, and the test tube containing Nucleotide;
(2) dissolve and packing enzyme and substrate according to test kit specification sheets ultrapure water, all reagent re-uses after need recovering room temperature;
(3) according to the volume that computer calculation goes out, in agent bin, enzyme, substrate and Nucleotide A, T, G, C (agent bin uses at most 30 times, and agent bin must be dry before use) is added.
After getting out PyroMark Q24 reagent, PyroMark Q24 instrument is tested in the steps below:
(1) PyroMark Q24 software is opened, click new assay (newly testing) → new AQ assay (new AQ test) → input catastrophe point sequence in sequence to analyze (sequence to be analyzed), click Generate Dispensation Order (generation allocation order), click and preserve;
(2) click new run (newly running) → Instrument method (instrumental method) → 007, then click the grid that will check order, click and be saved to USB flash disk;
(3) by the USB port before the USB flash disk inserting instrument containing operating file;
(4) orifice plate heated is put on instrument;
(5) label surface of agent bin (enzyme, substrate and Nucleotide) is put into instrument towards oneself, orifice plate put into by open holes board support frame, closes orifice plate support saddle frame and instrument lid;
(6) select Run (operation), and press OK;
(7) after entering Run (operation), the file that will run is selected by select (selection);
(8) instrument end of run after confirming that operating file is saved to USB flash disk, by close, takes out USB flash disk;
(9) open instrument, take out agent bin, and it is cleaned repeatedly, discarded orifice plate;
(10) when instrument does not run, select shutdown (shutdown) from master menu and press OK;
(11) when It is now safe to turn off the instrument (now can safety shutdown) occurs, can close instrument, power switch is positioned at after instrument.
(4) interpretation of result:
Open Pyromark Q24 software, analyze the type of API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150) and NPM-ALK fusion gene, analytical results is as following table:
Result shows, 3,8,11, No. 14 patients are that API2-MALT1 (A1446-M814) fusion gene is positive; 2,7,12, No. 15 patients are that API2-MALT1 (A1446-M1123) fusion gene is positive; 5, No. 9 patients are that API2-MALT1 (A1446-M1150) fusion gene is positive; 1,4,6,10, No. 13 patients are that NPM-ALK fusion gene is positive.
To sum up, apply test kit of the present invention can realize quick, easy, detect API2-MALT1 (A1446-M814), API2-MALT1 (A1446-M1123), API2-MALT1 (A1446-M1150) and NPM-ALK fusion gene efficiently, accurately.
About after those set forth of the present invention more than having read, those skilled in the art can do various amendment or change to the present invention, comprising the various changes of primer, these equivalent form of values belong to the scope defined in the application's appended claims equally.

Claims (6)

1. a Manganic pyrophosphate complex initiation method detects the primer pair of API2-MALT1 and NPM-ALK fusion gene simultaneously, wherein, described API2-MALT1 is any one or a few in A1446-M814, A1446-M1123 and A1446-M1150, and it is characterized in that, described primer pair comprises:
(1) for A1446-M814 gene:
Amplimer is:
Upstream primer: 5 '-GAAGCCTGGTAAAACAGACAGTTC-3 ',
Downstream primer: 5 '-CATCAGCTTTTGGGAAGTTGGT-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-CAACACTTCTCTGGAAGC-3′；
(2) for A1446-M1123 gene:
Amplimer is:
Upstream primer: 5 '-GAAGCCTGGTAAAACAGACAGTTC-3 ',
Downstream primer: 5 '-TTTCCTATCAAAAGGGCAACC-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-TGAGGAAAAAGAATCA-3′；
(3) for A1446-M1150 gene:
Amplimer is:
Upstream primer: 5 '-CAGAAGATGAAATAAGGGAAGAGG-3 ',
Downstream primer: 5 '-TATTTCCTATCAAAAGGGCAACC-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-GTCAGTTGTTTGCTCTTTA-3′；
(4) for NPM-ALK gene:
Amplimer is:
Upstream primer: 5 '-CAAAGTGAGATTACAGGCATGAGC-3 ',
Downstream primer: 5 '-GCTGGGATCTTGGTCAGTTGTGT-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer:
5′-GGTCAGTTGTGTTTCCTAT-3′。
2. a Manganic pyrophosphate complex initiation method detects the test kit of API2-MALT1 and NPM-ALK fusion gene simultaneously, described API2-MALT1 is any one or a few in A1446-M814, A1446-M1123 and A1446-M1150, it is characterized in that, described test kit comprises primer pair as described below:
(1) for A1446-M814 gene:
Amplimer is:
Upstream primer: 5 '-GAAGCCTGGTAAAACAGACAGTTC-3 ',
Downstream primer: 5 '-CATCAGCTTTTGGGAAGTTGGT-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-CAACACTTCTCTGGAAGC-3′；
(2) for A1446-M1123 gene:
Amplimer is:
Upstream primer: 5 '-GAAGCCTGGTAAAACAGACAGTTC-3 ',
Downstream primer: 5 '-TTTCCTATCAAAAGGGCAACC-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-TGAGGAAAAAGAATCA-3′；
(3) for A1446-M1150 gene:
Amplimer is:
Upstream primer: 5 '-CAGAAGATGAAATAAGGGAAGAGG-3 ',
Downstream primer: 5 '-TATTTCCTATCAAAAGGGCAACC-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer is:
5′-GTCAGTTGTTTGCTCTTTA-3′；
(4) for NPM-ALK gene:
Amplimer is:
Upstream primer: 5 '-CAAAGTGAGATTACAGGCATGAGC-3 ',
Downstream primer: 5 '-GCTGGGATCTTGGTCAGTTGTGT-3 ',
Wherein 5 ' end of downstream primer carries out biotin labeling;
Sequencing primer:
5′-GGTCAGTTGTGTTTCCTAT-3′。
3. test kit according to claim 2, is characterized in that, described test kit comprises quality control product, and described quality control product comprises positive reference substance and negative controls.
4. test kit according to claim 2, it is characterized in that, described positive reference substance is the mixed solution of the plasmid containing A1446-M814, A1446-M1123, A1446-M1150 and NPM-ALK, and described negative controls is not containing the plasmid solution of A1446-M814, A1446-M1123, A1446-M1150 and NPM-ALK.
5. primer pair according to claim 1 detects the application in the reagent of API2-MALT1 and NPM-ALK fusion gene in preparation.
6. test kit according to claim 2 detects the application in the reagent of API2-MALT1 and NPM-ALK fusion gene in preparation.
CN201410580123.7A 2014-10-24 2014-10-24 Manganic pyrophosphate complex initiation method detect simultaneously the primer of API2-MALT1 and NPM-ALK fusion gene to and test kit Active CN104357558B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410580123.7A CN104357558B (en) 2014-10-24 2014-10-24 Manganic pyrophosphate complex initiation method detect simultaneously the primer of API2-MALT1 and NPM-ALK fusion gene to and test kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410580123.7A CN104357558B (en) 2014-10-24 2014-10-24 Manganic pyrophosphate complex initiation method detect simultaneously the primer of API2-MALT1 and NPM-ALK fusion gene to and test kit

Publications (2)

Publication Number Publication Date
CN104357558A true CN104357558A (en) 2015-02-18
CN104357558B CN104357558B (en) 2016-08-03

Family

ID=52524864

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410580123.7A Active CN104357558B (en) 2014-10-24 2014-10-24 Manganic pyrophosphate complex initiation method detect simultaneously the primer of API2-MALT1 and NPM-ALK fusion gene to and test kit

Country Status (1)

Country Link
CN (1) CN104357558B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108085391A (en) * 2017-12-28 2018-05-29 广州市金圻睿生物科技有限责任公司 A kind of RNA quality-control products for the lung cancer fusion detection kit for stablizing preservation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101955995A (en) * 2010-06-17 2011-01-26 江苏迈迪基因生物科技有限公司 Combined detection method and diagnostic kit of fusion genes related to lymphoma

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101955995A (en) * 2010-06-17 2011-01-26 江苏迈迪基因生物科技有限公司 Combined detection method and diagnostic kit of fusion genes related to lymphoma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
府伟灵等主编: "《临床分子生物检验》", 31 August 2012 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108085391A (en) * 2017-12-28 2018-05-29 广州市金圻睿生物科技有限责任公司 A kind of RNA quality-control products for the lung cancer fusion detection kit for stablizing preservation
CN108085391B (en) * 2017-12-28 2021-01-19 广州市金圻睿生物科技有限责任公司 RNA quality control product of lung cancer fusion gene detection kit capable of being stably stored

Also Published As

Publication number Publication date
CN104357558B (en) 2016-08-03

Similar Documents

Publication Publication Date Title
Wang et al. Absolute quantification of lung cancer related microRNA by droplet digital PCR
EP2307028B1 (en) Use of mir-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
US8304188B2 (en) Barriers for facilitating biological reactions
AU2005271960B2 (en) Identification of markers in lung and breast cancer
US20230211347A1 (en) Systems and methods for continuous flow digital droplet polymerase chain reaction bioanalysis
Yu et al. Multiple authentications of high-value milk by centrifugal microfluidic chip-based real-time fluorescent LAMP
Reinholz et al. Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437
CN104911251A (en) Primer pair for detecting EML4-ALK fusion gene by pyrosequencing method and kit thereof
CN105112500A (en) Primers, probe and kit for detecting C-KIT gene mutation
CN105420416A (en) Direct real-time quantitative fluorescent PCR method of layered packaging tape indicator
Yeo et al. The usefulness of a novel fully automated PCR-based Idylla test for detection of the BRAF V600E mutation in thyroid tissue: comparison with PNA-clamping PCR, real-time PCR and pyrosequencing
CN105087764A (en) Detecting method for safely and quickly identifying porcine-derived materials in food and kit for detecting method
CN114364811A (en) Sample preparation apparatus with PCR chip and multi-well plate
CN104278092A (en) Primer pair and kit for detecting PML-RARA fusion gene by use of pyrophosphoric acid sequencing method
CN104313160A (en) Primer pair for simultaneously detecting CBFB-MYH11 and AML1-ETO fusion genes with pyrosequencing method and kit
CN104328178A (en) Primer pair for simultaneously detecting E2A-PBX1, TEL-AML1 and MLL-AF4 fusion genes by pyrosequencing process and kit including primer pair
US10533210B2 (en) Detection of methylated DNA
CN104357558A (en) Primer pair for simultaneously detecting API2-MALT1 and NPM-ALK fusion genes by pyrosequencing process and kit
Zhou et al. Rapid removal of cytology slide coverslips for DNA and RNA isolation
CN102643904A (en) Kit and method for detecting CYP19A1 gene polymorphism by pyrophosphoric acid sequencing method
CN104357557A (en) Primer pair for detecting NPM1 (nucleophosmin) gene mutation by pyrosequencing process and kit
CN104232765B (en) The primer pair of Manganic pyrophosphate complex initiation method detection BCR ABL fusion gene and test kit
CN107739757A (en) For detecting primer, probe and the kit of 37 1738 mutation of C KIT gene 17s
CN104278093A (en) Primer pair and kit for detecting SIL-TAL1 fusion genes by pyrosequencing method
WO2017013102A1 (en) Optimized clinical sample sequencing

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant